Pan European Prospective Observational Study of Fremanezumab effectiveness in patients with chronic or episodic migraine in the Real-World: PEARL study

First published 07/05/2020

Last updated 21/05/2025

EU PAS number:

EUPAS35111

Study

Finalised

Documents

Study protocol

Study results

Study report

Other information

Study, other information

PEARL Study Protocol a Real-World Study of Fremanezumab Effectiveness in Patients with Chronic or Episodic Migraine.pdf

English (1.09 MB - PDF) View document

Study, other information

Publications

Study publications

Secondary tabs